Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125762331 | 12576233 | 1 | I | 20160720 | 20160720 | 20160720 | EXP | CA-JNJFOC-20160716505 | JANSSEN | 48.00 | YR | A | M | Y | 113.00000 | KG | 20160720 | PH | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125762331 | 12576233 | 1 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | U | U | 125261 | 90 | MG | SOLUTION FOR INJECTION | ||||||
| 125762331 | 12576233 | 2 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 0 | TABLET | ||||||||||
| 125762331 | 12576233 | 3 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | 0 | 25 | MG | TABLET | ||||||||
| 125762331 | 12576233 | 4 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125762331 | 12576233 | 5 | C | PERINDOPRIL | PERINDOPRIL | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125762331 | 12576233 | 1 | Psoriasis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125762331 | 12576233 | HO |
| 125762331 | 12576233 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125762331 | 12576233 | Cellulitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |